title,content,url,timestamp,source,text,sentiment,confidence
Davos,"World leaders and business executives left the Swiss mountain resort of Davos after a week of discussions dominated from a distance by Donald Trump's return as U.S. President. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. All quotes delayed a minimum of 15 minutes.See here for a complete list of exchanges and delays. © 2025 Reuters.All rights reserved",https://www.reuters.com/business/davos/,2025-01-27T01:00:00Z,Reuters,"Davos. World leaders and business executives left the Swiss mountain resort of Davos after a week of discussions dominated from a distance by Donald Trump's return as U.S. President. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. All quotes delayed a minimum of 15 minutes.See here for a complete list of exchanges and delays. © 2025 Reuters.All rights reserved",,0.45736991808270455
Healthcare & Pharmaceuticals,"The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer that has advanced or spread despite previous treatments. Health insurers slideas US reaches government shutdown deal without extending subsidies FDA appoints veteran oncology chiefPazdur to leaddrug center Novo Nordisk, Lillystrike dealwith Trump to slash weight-loss drug prices FDA autism drug movesparks frenzy, but data lags behind US FDA proposes moves to speed availability of somecheaper biotechmedicines Event October 28-29·Chicago Event March 16-17·Philadelphia Event April 22-24·Barcelona Event May·Nashville Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. All quotes delayed a minimum of 15 minutes.See here for a complete list of exchanges and delays. © 2025 Reuters.All rights reserved",https://www.reuters.com/business/healthcare-pharmaceuticals/,2025-11-19T23:06:25Z,Reuters,"Healthcare & Pharmaceuticals. The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer that has advanced or spread despite previous treatments. Health insurers slideas US reaches government shutdown deal without extending subsidies FDA appoints veteran oncology chiefPazdur to leaddrug center Novo Nordisk, Lillystrike dealwith Trump to slash weight-loss drug prices FDA autism drug movesparks frenzy, but data lags behind US FDA proposes moves to speed availability of somecheaper biotechmedicines Event October 28-29·Chicago Event March 16-17·Philadelphia Event April 22-24·Barcelona Event May·Nashville Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. All quotes delayed a minimum of 15 minutes.See here for a complete list of exchanges and delays. © 2025 Reuters.All rights reserved",,0.38414449534003914
Future of Health,"The science and business powering tomorrow's medicine. U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss drugs like Wegovy and Zepbound from patients who lose only moderate amounts of weight at best, according to a report published online ahead of peer review. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. All quotes delayed a minimum of 15 minutes.See here for a complete list of exchanges and delays. © 2025 Reuters.All rights reserved",https://www.reuters.com/business/future-of-health/,2025-11-19T23:09:45Z,Reuters,"Future of Health. The science and business powering tomorrow's medicine. U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss drugs like Wegovy and Zepbound from patients who lose only moderate amounts of weight at best, according to a report published online ahead of peer review. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. All quotes delayed a minimum of 15 minutes.See here for a complete list of exchanges and delays. © 2025 Reuters.All rights reserved",,0.38134488323642823
World at Work,"How companies and countries are reimagining the way we work, live and play. Novartis will expand its operations in North Carolina and build a manufacturing hub there as part of a planned $23 billion of U.S. infrastructure investment over the next five years, the Swiss pharmaceuticals company said on Wednesday. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. All quotes delayed a minimum of 15 minutes.See here for a complete list of exchanges and delays. © 2025 Reuters.All rights reserved",https://www.reuters.com/business/world-at-work/,2025-11-19T18:59:47Z,Reuters,"World at Work. How companies and countries are reimagining the way we work, live and play. Novartis will expand its operations in North Carolina and build a manufacturing hub there as part of a planned $23 billion of U.S. infrastructure investment over the next five years, the Swiss pharmaceuticals company said on Wednesday. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. All quotes delayed a minimum of 15 minutes.See here for a complete list of exchanges and delays. © 2025 Reuters.All rights reserved",,0.385562256253532
